United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, has showcased a series of game-changing innovations at Arab Health 2025, solidifying pivotal ...

A downtrend has been apparent in Inhibikase Therapeutics, Inc. (IKT) lately. While the stock has lost 15.4% over the past two weeks, it could witness a trend reversal as a hammer chart pattern was ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Goldman Sachs BDC has a consensus target price of $13.00, suggesting a potential downside of 1.25%. Given Goldman Sachs BDC’s stronger consensus rating and higher probable upside, analysts ...

Investing.com - Inhibikase (NASDAQ: IKT) reported first quarter EPS of $-0.160, $0.02 worse than the analyst estimate of $-0.140. Revenue for the quarter came in at $64.52K versus... ByInvesting.com • ...

BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), today announced the appointment of two pharma industry executives with deep ...

BOSTON - Inhibikase Therapeutics, Inc. (NASDAQ:IKT), a clinical-stage pharmaceutical company with a market capitalization of $201.58 million, has announced the addition of two seasoned executives to ...